Laga active in private equity and venture capital work as investments in Belgian tech and biotech start-ups reach record levels

11 April 2018

Over the past year in Belgium, start-ups have experienced a surge in investments. The past quarter has seen record amounts being invested in tech and biotech start-ups.

Laga's Corporate - M&A practice has recently been very active with private equity and venture capital work, having been involved in several transactions that have contributed to the increasing levels of tech and biotech investment in Belgium. The firm advised investors in Syndesi Therapeutics, Rewind Therapeutics, Aelin Therapeutics and Act&Sorb, and assisted Proxyclick, Sensolus and Miracor with their respective investment matters.

Read recent coverage by De Tijd and L'Echo on the boom in start-up investments

Did you find this useful?